Neuropace, Inc. · NASDAQ:NPCE
Orbimed Advisors LLC reported a 8.00% stake in Neuropace, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Orbimed Advisors LLC reported a 8.00% stake in Neuropace, Inc., 2,614,184 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 8.00%
- Shares
- 2,614,184
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| OrbiMed Advisors LLC | 8.00% | 2,614,184 |
| OrbiMed Capital GP VI LLC | 8.00% | 2,614,184 |
Source
Related
- Neuropace, Inc.
- Orbimed Advisors LLC
- Neuropace, Inc. shareholders
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Orbimed Advisors LLC · May 15, 2026
- Schedule 13G/A · Orbimed Advisors LLC · May 15, 2025
- Form 4 · Morrell Martha · Sep 25, 2026
- Form 4 · Williams Patrick F. · Sep 21, 2026
- Form 4 · Becker Joel · Sep 4, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Sep 4, 2026
- Form 4 · Becker Joel · Aug 28, 2026